home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Inhibiting Inflammation In Multiple Sclerosis

  August, 2 2006 9:07
your information resource in human molecular genetics
T cells, a type of immune cell, can impede the development and progression of multiple sclerosis in mice, according to a paper to be published in the September 2006 issue of Nature Immunology.

Many different types of T cells exist, each expressing a unique T cell receptor that helps the cell sense and react appropriately to its environment. J. Ludovic Croxford and colleagues show that a specific subset of T cells slows the onset and decreases the severity of a mouse version of human multiple sclerosis. The disease is worsened in the absence of these T cells, which block autoimmunity at least in part by triggering other immune cells to release chemical mediators that dampen the inflammatory response. Whether these T cells are involved in human autoimmune disease, and whether they can be harnessed for therapeutic intervention, remains to be determined.

Author contact:

Takashi Yamamura (National Institute of Neuroscience, Tokyo, Japan)
E-mail: yamamura@ncnp.go.jp

J. Ludovic Croxford (National Institute of Neuroscience, Tokyo, Japan)
E-mail: ludo_von_crox@yahoo.co.uk

Abstract available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.